Dr. Ichiko Kinjyo is a Research Assistant Professor of Molecular Medicine at the University of New Mexico and Comprehensive Cancer Center. After she received her MD from Kagoshima University (Japan), she completed a PhD in Molecular Cellular Immunology at Kyushu University (Japan), with research about the immune regulation by suppressors of cytokine signaling (SOCS) family under the mentorship of Dr. Akihiko Yoshimura. She pursued postdoctoral training in the laboratory of Dr. Steven L Reiner at the University of Pennsylvania, where she learned T cell immunology through research about T cell fate determination. She conducted additional postdoctoral research about the cell cycle progression during CD8 T cell differentiation in Dr. Wolfgang Weninger’s lab at the Centenary Institute in Sydney. In the laboratory of Dr. Bridget S Wilson at the University of New Mexico, she investigated immunotoxin-based treatment against acute lymphoblastic leukemia. She also determined the novel mechanisms for brain metastasis of leukemia. In 2017, she joined Dr. Sarah F Adams’ lab for a research project about the combination of treatment with PARP inhibitors and immune checkpoint blockade against ovarian cancer. Her continuous interest in T cell biology inspired her toward cancer immunotherapy to reactivate anti-tumor T cells for effective cancer control.